These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 26518939)
41. Human complement-activating immunoglobulin (Ig)G3 antibodies are essential for porcine endothelial cell activation. Saethre M; Lea T; Borgen MS; Fiane AE; Michaelsen TE; Thorsby E; Haraldsen G; Mollnes TE Xenotransplantation; 2006 May; 13(3):215-23. PubMed ID: 16756564 [TBL] [Abstract][Full Text] [Related]
42. Thrombotic microangiopathy associated with humoral rejection of cardiac xenografts from alpha1,3-galactosyltransferase gene-knockout pigs in baboons. Shimizu A; Hisashi Y; Kuwaki K; Tseng YL; Dor FJ; Houser SL; Robson SC; Schuurman HJ; Cooper DK; Sachs DH; Yamada K; Colvin RB Am J Pathol; 2008 Jun; 172(6):1471-81. PubMed ID: 18467706 [TBL] [Abstract][Full Text] [Related]
43. Dissociation between anti-porcine albumin and anti-Gal antibody responses in non-human primate recipients of intraportal porcine islet transplantation. Kang HJ; Lee H; Park EM; Kim JM; Shin JS; Kim JS; Park CG; Park SH; Kim SJ Xenotransplantation; 2015; 22(2):124-34. PubMed ID: 25641336 [TBL] [Abstract][Full Text] [Related]
44. Inhibition of the membrane attack complex of complement for induction of accommodation in the hamster-to-rat heart transplant model. Suhr BD; Black SM; Guzman-Paz M; Matas AJ; Dalmasso AP Xenotransplantation; 2007 Nov; 14(6):572-9. PubMed ID: 17991145 [TBL] [Abstract][Full Text] [Related]
45. The role of anti-non-Gal antibodies in the development of acute humoral xenograft rejection of hDAF transgenic porcine kidneys in baboons receiving anti-Gal antibody neutralization therapy. Chen G; Sun H; Yang H; Kubelik D; Garcia B; Luo Y; Xiang Y; Qian A; Copeman L; Liu W; Cardella CJ; Wang W; Xiong Y; Wall W; White DJ; Zhong R Transplantation; 2006 Jan; 81(2):273-83. PubMed ID: 16436972 [TBL] [Abstract][Full Text] [Related]
46. [Effect of Yunnan-cobra venom factor in overcoming acute humoral rejection after allograft cardiac transplantation in presensitized recipients: experiment with rats]. Li R; Chen G; Guo H; Wang DW; Xie L; Wang SS; Wang WY; Xiong YL; Chen S Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(21):1460-3. PubMed ID: 16842697 [TBL] [Abstract][Full Text] [Related]
47. Therapeutic regulation of systemic inflammation in xenograft recipients. Iwase H; Liu H; Li T; Zhang Z; Gao B; Hara H; Wijkstrom M; Long C; Saari R; Ayares D; Cooper DKC; Ezzelarab MB Xenotransplantation; 2017 Mar; 24(2):. PubMed ID: 28294424 [TBL] [Abstract][Full Text] [Related]
48. Combination of decay-accelerating factor expression and alpha1,3-galactosyltransferase knockout affords added protection from human complement-mediated injury. van Denderen BJ; Salvaris E; Romanella M; Aminian A; Katerelos M; Tange MJ; Pearse MJ; d'Apice AJ Transplantation; 1997 Sep; 64(6):882-8. PubMed ID: 9326415 [TBL] [Abstract][Full Text] [Related]
49. Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys. Chen G; Qian H; Starzl T; Sun H; Garcia B; Wang X; Wise Y; Liu Y; Xiang Y; Copeman L; Liu W; Jevnikar A; Wall W; Cooper DK; Murase N; Dai Y; Wang W; Xiong Y; White DJ; Zhong R Nat Med; 2005 Dec; 11(12):1295-8. PubMed ID: 16311604 [TBL] [Abstract][Full Text] [Related]
50. Decomplementation with cobra venom factor prolongs survival of xenografted islets in a rat to mouse model. Oberholzer J; Yu D; Triponez F; Cretin N; Andereggen E; Mentha G; White D; Buehler L; Morel P; Lou J Immunology; 1999 May; 97(1):173-80. PubMed ID: 10447729 [TBL] [Abstract][Full Text] [Related]
52. Complement and myoblast transfer therapy: donor myoblast survival is enhanced following depletion of host complement C3 using cobra venom factor, but not in the absence of C5. Hodgetts SI; Grounds MD Immunol Cell Biol; 2001 Jun; 79(3):231-9. PubMed ID: 11380675 [TBL] [Abstract][Full Text] [Related]
53. Use of lentiviral vectors to induce long-term tolerance to gal(+) heart grafts. Kearns-Jonker M; Fischer-Lougheed J; Shulkin I; Kleihauer A; Mitsuhashi N; Kohn DB; Weinberg K; D'Apice AJ; Starnes VA; Cramer DV Transplantation; 2004 Jun; 77(11):1748-54. PubMed ID: 15201677 [TBL] [Abstract][Full Text] [Related]
54. Anti-galactose-alpha(1,3) galactose antibody production in alpha1,3-galactosyltransferase gene knockout mice after xeno and allo transplantation. Chong A; Blinder L; Ma L; Yin D; Shen J; Williams JW; Byrne G; Schwarz A; Diamond LS; Logan JE Transpl Immunol; 2000 Jun; 8(2):129-37. PubMed ID: 11005319 [TBL] [Abstract][Full Text] [Related]
55. Characterization of a CD46 transgenic pig and protection of transgenic kidneys against hyperacute rejection in non-immunosuppressed baboons. Loveland BE; Milland J; Kyriakou P; Thorley BR; Christiansen D; Lanteri MB; Regensburg M; Duffield M; French AJ; Williams L; Baker L; Brandon MR; Xing PX; Kahn D; McKenzie IF Xenotransplantation; 2004 Mar; 11(2):171-83. PubMed ID: 14962279 [TBL] [Abstract][Full Text] [Related]
56. Naturally acquired anti-alpha Gal antibodies in a murine allograft model similar to delayed xenograft rejection. Salvaris E; Gock H; Han W; Murray-Segal L; Barlow H; Mottram P; Pearse M; Cowan P; Goodman D; d'Apice AJ Xenotransplantation; 2000 Feb; 7(1):42-7. PubMed ID: 10809056 [TBL] [Abstract][Full Text] [Related]